2023-08-07 13:36:26 ET
- Amicus Therapeutics ( NASDAQ: FOLD ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, before market open.
- The consensus EPS Estimate is -$0.11 and the consensus Revenue Estimate is $89.87M (+11.4% Y/Y).
- Over the last 1 year, FOLD has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 4 downward. Revenue estimates have seen 5 upward revisions and 5 downward.
For further details see:
Amicus Therapeutics Q2 2023 Earnings Preview